My Gene Counsel
  • Labs & Precision Medicine
  • Health Systems & Clinical Partners
  • BIOPHARMA, CLINICAL TRIALS & PAYERS
  • Solutions
    • My Gene Screen
    • Living Lab Reports
    • Genetic Alerts
  • Media
    • Genetic Journal
    • News
    • Press Releases
    • Multimedia
    • Publications
    • Career Resources
    • Case Series
  • About Us
  • Login
Select Page
Tennis Star Chris Evert Teaches Us That Genetic Testing Is a Lifetime Match

Tennis Star Chris Evert Teaches Us That Genetic Testing Is a Lifetime Match

by Danielle Bonadies | Jan 17, 2022 | News

This weekend, Chris Evert tweeted that she was diagnosed with early-stage (Stage 1C) ovarian cancer, which is associated with an outstanding survival rate. This news is especially good because most people diagnosed with ovarian cancer are diagnosed at stage III or IV,...
My Gene Counsel Quoted in Washington Post and Kaiser Health News

My Gene Counsel Quoted in Washington Post and Kaiser Health News

by Danielle Bonadies | Feb 9, 2021 | News

As seen on The Washington Post and Kaiser Health News By Christina Bennett When her gynecologist recommended genetic testing, Mai Tran was reluctant. “I didn’t really want to do it,” recalled Tran, who had just turned 21 and was living in New...
With More Than a Million Records, ClinVar Value Grows as Variant Classification Resource

With More Than a Million Records, ClinVar Value Grows as Variant Classification Resource

by Danielle Bonadies | Jan 9, 2020 | News

Since its launch in 2013, ClinVar has not only amassed a wealth of genetic variant information, but the lab and clinical genetics community in the US are readily referencing it when they have questions about the clinical significance of variants. A few healthcare...
Scalable Updating Return of Genetic Test Results From 2018 Forward

Scalable Updating Return of Genetic Test Results From 2018 Forward

by Danielle Bonadies | May 26, 2018 | Genetic Journal

The National Cancer Institute hosts a webinar series called Ethical and Regulatory Issues in Cancer Research (ENRICH). This speaker series fosters discussion about ethical and regulatory issues impacting cancer research. Our CEO/President, Ellen Matloff, was the...
VUS Reclassified to Suspected Deleterious: When Genetic Counseling Updates Become Lifesaving

VUS Reclassified to Suspected Deleterious: When Genetic Counseling Updates Become Lifesaving

by Danielle Bonadies | Nov 30, 2017 | Genetic Journal

Mary Ellen always knew that her family history included cancer. Her mom was diagnosed with breast cancer in her 50s and died in her 60s. Early-onset breast cancer, prostate cancer, and possible ovarian cancers were seen in aunts, uncles, and cousins. So, it was not...
12Next >

Recent Posts

  • Genetic Testing Challenges in Precision Medicine: Lab Fails to Report NF2 Mosaic Variant
  • Career Compass: Tips and Tricks for Second Year Students and Recent Graduates with Christina Frater
  • Continuing Education Opportunities
  • ABGC Boards Resources
  • The Speed and Scope of Genetic Updates | My Gene Counsel

Archives

  • About Us
  • Media
  • Genetic Journal Blog
  • Labs & Precision Medicine
  • Health Systems & Clinical Partners
  • Biopharma, Clinical Trials & Payers
  • My Gene Screen
  • Living Lab Reports®
  • Genetic Alerts
  • Contact Us
  • FAQs
  • Career Resources

The My Gene Counsel portal and website should not be construed, directly or indirectly, as the practice of medicine or dispensing of medical services by My Gene Counsel or its Partners.

My Gene Counsel   ©